Frontiers | Immune dysregulation in Good’s syndrome: Mechanisms, autoantibodies, and therapeutic perspectives

CH
chiung-hui huang
Department of Pediatrics, Khoo Teck Puat – National University Children’s Medical Institute
Singapore
HG
hyun-il gil
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine
Republic of Korea
JL
jinlin liu
Department of Clinical Laboratory, South China Hospital, Medical School, Shenzhen University
China
LY
louis yi ann yi ann chai
Division of Infectious Diseases, Department of Medicine, National University Health System
Singapore
YK
yae-jean kim
Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University
Republic of Korea
AS
anindita santosa
Department of Medicine, Changi General Hospital
Singapore
AS
areum shin
Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University
Republic of Korea
BW
byung woo jhun
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine
Republic of Korea
DW
dongling wang
Defence Medical and Environmental Research Institute, DSO National Laboratories
Singapore
DR
doo ri kim
Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University
Republic of Korea
GG
gladys gek yen tan
Defence Medical and Environmental Research Institute, DSO National Laboratories
Singapore
JK
jae-hoon ko
Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine
Republic of Korea

Immune dysregulation in Good’s syndrome: Mechanisms, autoantibodies, and therapeutic perspectives